Sponsors Urged To ‘Push Back’ On EU Country-Specific Clinical Trial Requirements
Executive Summary
It has been over five months since the EU Clinical Trial Regulation introduced harmonized requirements for approving new studies. A top European Commission official says that trial sponsors need to keep driving this message home to member states, who are clinging on to their national requirements out of habit.
You may also be interested in...
Updated EU Guide Helps Sponsors Steer Through National Clinical Trial Requirements
The EU guideline on the Clinical Trials Regulation has been updated with a list of member state websites where sponsors can find information on national requirements for trial applications.
CTIS: EU Member States Seek Advance ‘Warning’ On Lead Assessor Requests
Sponsors keen on a specific EU member state to lead the assessment of their proposed multinational clinical trial are being urged to keep the concerned national competent authority in the loop before submitting the dossier to the Clinical Trial Information System.
EU Clinical Trial Sponsors Reassured On Member State Dossier Requirements
The European Commission wants to ensure that the content of dossiers filed under the EU Clinical Trial Regulation is harmonized to simplify the trial approval process. Any national requirements imposed by member states should have a clear legal basis.